Technology and expertise
to fit your needs
Emerging and Mid-Sized Biopharma companies rely on Medidata to gain speed, scale as complexity increases, mitigate risks, and improve trial outcomes.
Medicenna: Solving the Impossible in Glioblastoma with Medidata Acorn AI Synthetic Control Arm® (SCA®)
Hear how Medicenna Therapeutics, Inc worked with the Acorn AI team to become the first to get an FDA agreement to design a phase 3 registrational trial using an external control arm.
Proven innovative technology fit to your needs
Transformative technology for early-stage research now, that scales as study design complexity increases tomorrow. Battle tested on over 3K Phase I Studies and 2.6K+ Single Site Studies.
Mitigate risk with the ecosystem trusted by life science partners
Medidata puts your trials at the center of the life science ecosystem. Our relationships span across academic, regulatory, patient advocacy and scientific organizations of all sizes. Trusted by 900k+ site/sponsors and over 150 global CROs and partners.
Move faster with dedicated support and expertise
Leverage best practices from 24,000+ trials and 1,200 relationships with emerging and mid-size biopharma companies to improve your trial outcomes.
Right-size your team, access data to make better decisions, pivot faster, generate “evidence” needed, and position for regulatory success.
One technology platform to power people, processes, and progress.
Medidata helps Emerging and Mid-Sized Biopharma companies adapt, simplify, scale, and accelerate their clinical trials, from protocol design to study startup, conduct, close-out, and commercialization.
Our platform is built to enable you with cloud-based, modular, integrable, easily configurable capabilities, all powered by the latest patient, clinical and operational data, and AI solutions.
To adapt, scale, and meet increasing requirements for virtual, decentralized, and hybrid trials, Emerging and Mid-Sized Biopharma companies need a path to gain immediate advantage and leap into the next generation of clinical trials.
Within one scalable platform, Medidata enables remote patients to discover, evaluate, and enroll in your study virtually.
Continuous remote monitoring of document review, targeted source data verification, and site activities enable risk remediation in real-time and with a fully auditable solution. Sites also gain efficiencies with the adoption of a single, standardized Imaging technology, delivering control and flexibility.
Supporting 360+ industry-sponsored COVID-19 studies in 70+ countries, Medidata teams up with Emerging and Mid-Sized Biopharma companies to pivot, adapt, and future proof their remote technologies to meet long-term compliance and future disruptions.
Adapting for more complex, globally dispersed trials and new technologies is compounded by unrelenting pressures to rein in cycle times and budgets. Emerging and Mid-Sized Biopharma companies look to unify critical processes to improve and transform the clinical trial experience for patients, sponsors, CROs, and research sites.
Accelerate study startup, access data, connect work, and scale and manage trials faster, all in one place.
Use a single sign-on (SSO) to centralize your workflows, data, and operations in one system for a continuous work experience across your teams. Leverage systematic and seamless processes to eliminate duplicate data entry, multiple data migrations, or unnecessary reconciliation efforts.
Operate with a single view of all cross-application data and activities to maintain full control, improve inspection readiness and operational efficiencies.
In the new reality, Emerging and Mid-Sized Biopharma companies are required to launch, adapt, and pivot new and existing trials faster than ever. At the core of this new paradigm is data.
Optimize your trial design, operational feasibility, and trial performance according to data and predictive models benchmarking protocol, site and patient burden, and procedural cost. Leverage RWD to expand and better understand patient populations.
Accelerate enrollment through precise study, country, and site insights driven by cross-industry performance data and predictive models.
Improve study integrity, reduce risk, optimize efficiency and patient safety, unifying data capture and management in a single place for actionable insights and faster decision making.
Gain the ability to detect errors, trends, and anomalies to proactively perform root cause investigations and take corrective actions. Reduce trial risks with an RBQM approach to proactively enhance data quality.
As an Emerging or Mid-Sized Biopharma, you seek to adapt your patient-centric approach to leverage insights and optimize engagement at every stage of your trials.
Leverage cross-industry clinical trial data from 6 million patients and +23,000 trials to optimize your protocol feasibility, improve recruitment, and benchmark your study design to minimize patient burden and boost engagement and retention. Deliver powerful insights and the necessary evidence to increase the probability of success by connecting with real world data.
Use technology solutions designed from the patient perspective to meet patient preferences for data collection and participation, and seamlessly integrate into their everyday lives, improving the overall experience in clinical research operations.